French Body Welcomes Call For Greater Uptake

Spending Analysis Urges Action To Boost Generics And Biosimilars

French generics and biosimilar body Gemme has welcomed a call from the country’s audit court to improve uptake for off-patent medicines.

Uptake of generics and biosimilars in France needs to be higher (Shutterstock)

More from Generics

More from Policy & Regulation